80277-06-1Relevant articles and documents
Rational design of NIR fluorescence probes for sensitive detection of viscosity in living cells
Zhang, Gaobin,Ni, Yun,Zhang, Duoteng,Li, Hao,Wang, Nanxiang,Yu, Changmin,Li, Lin,Huang, Wei
, p. 339 - 347 (2019)
Developing near-infrared (NIR) fluorescence probes for detection of intracellular viscosity is still sufficiently challenging. In this work, three kinds of D-A-D type naphthyl and 2,1,3?benzoxadiazol hybrid NIR dyes functionalized with amino (NY1), N?methylamino (NY2) and N,N?dimethylamino (NY3) groups for intracellular micro-viscosity detection were designed and synthesized. All the probes exhibited very weak NIR emission in low viscosity environment and obvious fluorescence enhancement with the increased viscosity. Different substituent groups had a high impact on the photophysical properties and response sensitive of the probes to viscosity. The structure-property relationships were systematic investigated. The results showed that stronger electron-donating ability and larger steric effect of N,N?dimethylamino led to a narrower energy gap and more sensitive to viscosity environment. Therefore, NY3 exhibited higher signal noise ratio for viscosity detection and was successfully applied for imaging the changes of intracellular micro-viscosity. This work provides an efficient way to design powerful NIR fluorescence probes for viscosity detection.
Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans
-
Paragraph 0065; 0258, (2018/08/20)
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of
DRUGS FOR INHIBITING P38 AND USES THEREOF
-
Paragraph 0086, (2014/09/29)
The present invention relates to compounds with a benzoxadiazolyl amine structure which are capable of inhibiting the activation or the biological activity of p38 mitogen-activated protein kinase (MAPK) and the use thereof in the treatment of a disease th